Skip to main content

Man Group PLC : Form 8.3 – American Axle and Manufacturing Holdings Inc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree American Axle & Manufacturing Holdings, Inc.(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For...

Continue reading

AKVA group ASA: Completion of intragroup merger with AKVA group Software AS and Polarcirkel AS

References are made to the stock exchange announcements by AKVA group ASA (AKVA) on 7 November 2024 and 17 December 2024 regarding the intragroup mergers of AKVA’s wholly owned subsidiaries AKVA group Software AS and Polarcirkel AS, both as the non-surviving entities with AKVA as the surviving entity. The mergers have now been completed upon the registration of the mergers by the Norwegian Register of Business Enterprises. This information is subject to the disclosure requirements pursuant to section 4.2.4 of Oslo Rule Book II – Issuer Rules, cf. section 5-12 of the Norwegian Securities Trading Act. Dated: 7 February 2025AKVA group ASA Web: www.akvagroup.com CONTACTS:Knut Nesse Chief Executive OfficerPhone: +47 51 77 85 00Mobile: +47 91 37 62 20E-mail: knesse@akvagroup.comRonny Meinkøhn Chief Financial OfficerPhone: +47...

Continue reading

Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe plaque psoriasis on track for readout in first half of 2026; Topline data from Phase 2b LUMUS trial in systemic lupus erythematosus on track for readout in 2026 Evaluation underway of development plan for ACELYRIN’s lonigutamab to confirm differentiation in a capital efficient manner Pro forma cash position of approximately $737 million as of December 31, 2024, provides runway into 2027, beyond expected multiple clinical readouts for highly differentiated late-stage portfolio Alumis and ACELYRIN stockholders to own ~55% and ~45%, respectively, of combined company on a fully diluted basis Combined company will operate under Alumis name with current Alumis executive team Conference call to be held today, February 6, 2025, at 5:00 PM ET SOUTH SAN FRANCISCO,...

Continue reading

Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

Topline data from Phase 3 ONWARD trials for Alumis’ ESK-001 in moderate-to-severe plaque psoriasis on track for readout in first half of 2026; Topline data from Phase 2b LUMUS trial in systemic lupus erythematosus on track for readout in 2026 Evaluation underway of development plan for ACELYRIN’s lonigutamab to confirm differentiation in a capital efficient manner Pro forma cash position of approximately $737 million as of December 31, 2024, provides runway into 2027, beyond expected multiple clinical readouts for highly differentiated late-stage portfolio Alumis and ACELYRIN stockholders to own ~55% and ~45%, respectively, of combined company on a fully diluted basis Combined company will operate under Alumis name with current Alumis executive team Conference call to be held today, February 6, 2025, at 5:00 PM ET SOUTH SAN FRANCISCO,...

Continue reading

JCDecaux Top Media acquires High Traffic Media in Panama

JCDecaux Top Media acquires High Traffic Media in Panama  Paris, February 6th, 2025 – JCDecaux SE (Euronext Paris: DEC), the number one outdoor advertising company worldwide, announces that its majority-owned subsidiary JCDecaux Top Media has acquired High Traffic Media, a key player in outdoor advertising in Panama (population: 4.4 million). Created in 2007 by Juan Raul Perez, the Panamanian company High Traffic Media has a large portfolio of analogue and digital billboard assets in the capital city and operates in the Panama City Metro as well as in the country’s largest shopping malls, including Multiplaza Panamá, one of the most modern and busiest in the region. JCDecaux, the number one outdoor advertising company in Latin America, particularly in Central America, established itself in Panama in 2013 with the acquisition of Eumex...

Continue reading

Healthmap Solutions Acquires Carium to Enhance Digital Engagement Capabilities within Healthmap’s Population Health Management Platform

TAMPA, Fla., Feb. 06, 2025 (GLOBE NEWSWIRE) — Healthmap Solutions, Inc. (Healthmap), an industry-leading kidney population health management company, has announced its acquisition of Carium, a digital care management and communication platform. Healthmap will leverage Carium’s end-to-end technology solutions to enhance its Kidney Population Health Management program through additional patient and provider engagement capabilities. Both Healthmap and Carium have established themselves as trusted partners in the healthcare industry by enhancing patient and provider engagement and improving care coordination through technology. Healthmap partners with health plans, health systems, accountable care organizations (ACOs), and provider groups to optimize the care and outcomes of patients with kidney disease, while lowering costs for clients....

Continue reading

Jeffs’ Brands Enters Into Definitive Agreement to Complete Fort Products’ Merger with a Publicly Traded Company, at a Valuation of up to approximately $12 Million

Tel Aviv, Israel, Feb. 06, 2025 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced it that, further to its press release on January 3, 2025, is has entered into a definitive agreement to complete the contemplated merger of Fort Products Limited, a UK-based private company and a wholly owned subsidiary of the Company (“Fort Products”), with Impact Acquisitions Corp. (“Impact”), a capital pool company listed on the TSX Venture Exchange (the “Proposed Merger”). Under the definitive share purchase agreement (the “Definitive Agreement”), Impact Acquisitions will acquire from the Company 100% of Fort Products’ equity interests. Jeffs Brands will receive 75.02% and up to 83.29% ownership of Impact share...

Continue reading

ZRG Acquires Aspen Leadership Group, Cementing Market Leadership in Education Talent Solutions

ROCHELLE PARK, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) — ZRG, one of the world’s fastest-growing global talent advisory and executive search firms, today announced the acquisition of Aspen Leadership Group (ALG), the premier firm in placing and supporting fundraising and other leaders in education and the broader nonprofit sector. This strategic acquisition reinforces ZRG’s leadership position and ongoing investment in higher education, where synergies between Aspen Leadership Group and ZRG’s expanding, industry-leading portfolio establish the most comprehensive talent solution suite available today. Together the firms bring unmatched expertise across executive search, interim leadership, consulting/coaching, and embedded recruiting. With ALG’s specialized focus in development and advancement, and its complementary expertise in finance...

Continue reading

Ontex reaches binding agreement to sell its Turkish subsidiary to Dilek Grup

Aalst, Belgium, February 5, 2025 – Ontex Group NV [EURONEXT: ONTEX], a leading international developer and producer of personal care solutions, announces that it has entered into a binding agreement to sell its Turkish subsidiary to Dilek Grup. The transaction includes Ontex’s business in Türkiye and related export business, as well as its plant in Istanbul. Ontex’s Turkish subsidiary develops, manufactures, commercializes and distributes predominantly branded personal hygiene products with leading positions in Türkiye and the surrounding regions. Ontex’s Turkish subsidiary generated about €90 million sales in 2024 and is part of Ontex’s Emerging Markets division, which has been classified as discontinued operations. Dilek Grup is an established distributor of fast-moving consumer goods across Türkiye and neighboring countries, and it...

Continue reading

Techmer PM Acquires Colors for Plastics to Broaden Product Offerings

Techmer’s Latest Acquisition Strengthens Market Position and Drives Innovation in Polymer Solutions CLINTON, Tenn., Feb. 05, 2025 (GLOBE NEWSWIRE) — Techmer PM, a leading materials design company specializing in polymer modification for masterbatch and engineered compounds, is pleased to announce the acquisition of Colors for Plastics, a provider of color concentrates and custom color solutions. This strategic acquisition enhances Techmer PM’s capabilities and expands its product offerings to better serve its diverse customer base. “This acquisition allows us to leverage the Colors for Plastics team’s knowledge and experience in color technology, further strengthening our position as a leader in the industry,” said Mike McHenry, chief executive officer of Techmer PM. “We look forward to welcoming Colors...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.